The Role of Boc-Tyr(tBu)-Aib-OH in Advanced Organic Synthesis
Organic synthesis is the art and science of creating complex molecules from simpler precursors, a fundamental practice in both academic research and industrial production. Within this domain, specialized building blocks are essential for constructing molecules with precise structures and functionalities. Boc-Tyr(tBu)-Aib-OH (CAS: 2639221-78-4), a high-purity protected amino acid derivative offered by NINGBO INNO PHARMCHEM CO.,LTD., plays a significant role as a versatile intermediate in advanced organic synthesis.
The compound's chemical structure, featuring both the tert-butoxycarbonyl (Boc) protecting group and the alpha-aminoisobutyric acid (Aib) moiety, makes it an exceptionally useful building block. The Boc group provides facile deprotection under mild acidic conditions, allowing for selective chemical modifications. The Aib residue, a non-proteinogenic amino acid, introduces unique structural and conformational properties into synthesized molecules, often enhancing their stability and bioactivity.
In organic synthesis, Boc-Tyr(tBu)-Aib-OH is utilized in a variety of reactions to create complex molecular architectures. It serves as a crucial intermediate in the synthesis of peptides, including those with therapeutic applications such as Tirzepatide. Its incorporation into larger molecules allows chemists to precisely control stereochemistry and introduce specific functionalities, which are critical for achieving desired outcomes in drug discovery and material science.
NINGBO INNO PHARMCHEM CO.,LTD., a reputable supplier from China, ensures that Boc-Tyr(tBu)-Aib-OH is available with high purity (99%), meeting the rigorous demands of synthetic chemists. Access to reliable sources of such building blocks is vital for the advancement of organic synthesis, enabling the creation of novel compounds that can lead to significant scientific and technological breakthroughs. By providing this essential intermediate, NINGBO INNO PHARMCHEM CO.,LTD. supports innovation across various chemical disciplines.
The compound's chemical structure, featuring both the tert-butoxycarbonyl (Boc) protecting group and the alpha-aminoisobutyric acid (Aib) moiety, makes it an exceptionally useful building block. The Boc group provides facile deprotection under mild acidic conditions, allowing for selective chemical modifications. The Aib residue, a non-proteinogenic amino acid, introduces unique structural and conformational properties into synthesized molecules, often enhancing their stability and bioactivity.
In organic synthesis, Boc-Tyr(tBu)-Aib-OH is utilized in a variety of reactions to create complex molecular architectures. It serves as a crucial intermediate in the synthesis of peptides, including those with therapeutic applications such as Tirzepatide. Its incorporation into larger molecules allows chemists to precisely control stereochemistry and introduce specific functionalities, which are critical for achieving desired outcomes in drug discovery and material science.
NINGBO INNO PHARMCHEM CO.,LTD., a reputable supplier from China, ensures that Boc-Tyr(tBu)-Aib-OH is available with high purity (99%), meeting the rigorous demands of synthetic chemists. Access to reliable sources of such building blocks is vital for the advancement of organic synthesis, enabling the creation of novel compounds that can lead to significant scientific and technological breakthroughs. By providing this essential intermediate, NINGBO INNO PHARMCHEM CO.,LTD. supports innovation across various chemical disciplines.
Perspectives & Insights
Logic Thinker AI
“The Aib residue, a non-proteinogenic amino acid, introduces unique structural and conformational properties into synthesized molecules, often enhancing their stability and bioactivity.”
Molecule Spark 2025
“In organic synthesis, Boc-Tyr(tBu)-Aib-OH is utilized in a variety of reactions to create complex molecular architectures.”
Alpha Pioneer 01
“It serves as a crucial intermediate in the synthesis of peptides, including those with therapeutic applications such as Tirzepatide.”